Back to search

Article

Pharmacokinetics and <i>In vivo</i> Efficacy of Epetraborole against <i>Burkholderia pseudomallei</i>

2025-07-14

Abstract excerpt

Melioidosis, caused by Burkholderia pseudomallei , remains a major therapeutic challenge due to high relapse rates and intrinsic antibiotic resistance. Epetraborole (EBO), a leucyl-tRNA synthetase inhibitor, represents a novel therapeutic approach with a distinct mechanism of action compared to standard-of-care antibiotics. Preclinical studies included MIC determination, pharmacokinetic (PK) profiling, dose range...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
82343527-8d55-57cc-b1d7-bd25b21744d4
DOI
10.1101/2025.07.10.664055
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacokinetics and <i>In vivo</i> Efficacy of Epetraborole against <i>Burkholderia pseudomallei</i>DOI 10.1101/2025.07.10.664055
Select a neighboring publication to make it the new centre.